Offerings
Products
Distribution Products
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Large Cap

Dr. Reddy's Labs Share Price

Dr. Reddy's Laboratories Ltd.

₹1,281.70

-12.20(-0.94%)

Invest in DRREDDY with up to 4.00x margin.

Trade with MTF

11th May 2026 | 3:28 PM

NSE : DRREDDY

Open Free Demat Account

Dr. Reddy's Labs Performance

Price Movement

₹1281.70

₹1272.50

₹1299.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1281.70

₹1138.50

₹1379.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,299.90

Low₹1,272.50

Open at₹1,288.00

Prev Close₹1,293.90

Volumes15.07 L

Avg Price₹1,286.59

Lower Circuit₹1,164.60

Upper Circuit₹1,423.20

Historical Performance

3M High₹1,375.90

3M Low₹1,167.50

1 Yr High₹1,379.70

1 Yr Low₹1,143.90

3 Yr High₹1,421.49

3 Yr Low₹876.81

5 Yr High₹1,421.49

5 Yr Low₹730.80

Dr. Reddy's Labs Fundamentals

Market Cap

High in industry

1,06,827.70 Cr.

PE Ratio (TTM)

Below industry Median

19.20

Dividend Yield

Below industry Median

0.60

Net Profit TTM

3.7% incr over last year

5,568.40

Net Profit Growth

3.7% incr over last year

5,568.40

PEG Ratio

High in industry

5.20

ROE

15% decr over last year

16.85

Operating Revenue TTM

34,682.20

Operating Revenue Growth

11.1% incr over last year

Book Value

Above industry Median

2.90

MFI

MFI Overbought

72.66

RSI

RSI is mid-range

52.57

EPS (TTM)

67.89

Debt to Equity

0.12

Face Value

Operating Profit Margin Qtr.

25.33

Operating Profit Qtr.

1,887.50

Net Profit Qtr.

1,209.90

Operating Revenue Qtr.

8,753.40

PB Ratio

2.90

Dr. Reddy's Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	4,282.70	4,618.60	7,809.50	5,562.90	5,015
Operating Expense	4,183.10	4,138.30	3,972.50	4,016.30	3,822.60
Operating Profit	99.60	480.30	3,837	1,443	1,192.40
Depreciation	314.30	294.80	279.80	264.50	265.10
Interest	41.40	33.40	19.20	31.10	43.30
Tax	13.60	129	975.10	361.10	270
Net Profit	90.60	387.30	2,961.20	1,200.70	849.40

Dr. Reddy's Labs Technicals

Dr. Reddy's Laboratories Ltd. EMA & SMA

₹1281.70

-12.20 (-0.94%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1300.4

Day EMA10 ₹1297.4

Day EMA12 ₹1294.7

Day EMA20 ₹1285.5

Day EMA26 ₹1281.1

Day EMA50 ₹1272.4

Day EMA100 ₹1265

Day EMA200 ₹1258.8

Dr. Reddy's Labs Support and Resistance

Resistance

First Resistance₹1306.07

Second Resistance₹1318.23

Third Resistance₹1326.27

Support

First Support₹1285.87

Second Support₹1277.83

Third Support₹1265.67

Technical Indicators

Day RSI52.57

Day MFI72.66

Day ADX25.16

Day Commodity Channel Index37.30

William-48.87

Day MACD13.64

Day MACD Signal Line11.57

Day ATR37.33

Day ROC1258.19

Day ROC218.18

Dr. Reddy's Labs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	26.6	26.6	26.6	26.6	26.6	26.6
FII	26.8	25.8	25.3	24.7	22.3	21.1
DII	36.2	37.1	37.8	38.8	41.3	42.7
Public	10.2	10.2	10	9.6	9.5	9.3

Dr. Reddy's Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	4.42 L	10 L	44.21%
Week	9.73 L	21.07 L	46.17%
1 Month	13.33 L	32.43 L	41.11%
6 Month	10.82 L	20.02 L	54.07%

Dr. Reddy's Labs SWOT Analysis

Strengths12

Weakness10

Opportunity4

Threats2

Benjamin Graham Value Screen

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Turnaround Potential (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Upcoming results with Rising Delivery Volumes

Affordable Stocks with High ROE and Momentum

High Momentum Scores (Technical Scores greater than 50)

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stocks near 52 Week High with Significant Volumes

Dr. Reddy's Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
10 Jul, 2025	8	FINAL	10 Jul, 2025	Equity Share
16 Jul, 2024	40	FINAL		Equity Share
11 Jul, 2023	40	FINAL		Equity Share
11 Jul, 2022	30	FINAL		Equity Share
09 Jul, 2021	25	FINAL		Equity Share
13 Jul, 2020	25	FINAL		Equity Share
15 Jul, 2019	20	FINAL		Equity Share
16 Jul, 2018	20	FINAL		Equity Share
17 Jul, 2017	20	FINAL		Equity Share
18 Jul, 2016	20	FINAL		Equity Share

Dr. Reddy's Labs Stock Comparison

Financials	Anthem Biosciences Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹785.75	₹1,128.80	₹1,802.10	₹1,685	₹2,460	₹184.04
% Change	0.14%	1.18%	-1.80%	2.56%	1.20%	2.33%
Revenue TTM (₹ Cr)	₹1,996.59	₹2,169.86	₹1,419.33	₹9,203.54	₹13,914.08	₹8,869.07
Net Profit TTM (₹ Cr)	₹484.66	₹332.94	₹20.10	₹924.36	₹1,779.35	₹-325.93
PE TTM	90.90	71.70	1028.50	34.40	57.30	-75.10
1 Year Return	37.58	59.77	13.47	66.53	2.52	-11.37
ROCE	26.88	12.51	3.26	25.65	13.27	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2810.00

+2.77%

GLAND

Gland Pharma Ltd.

₹ 1911.00

+0.35%

LAURUSLABS

Laurus Labs Ltd.

₹ 1270.00

+3.39%

ALKEM

Alkem Laboratories Ltd.

₹ 5585.00

-0.01%

BIOCON

Biocon Ltd.

₹ 392.05

+3.06%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6710.00

-0.01%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3051.20

+0.53%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2342.00

-1.03%

WOCKPHARMA

Wockhardt Ltd.

₹ 1626.00

+1.21%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1483.00

-0.29%

NATCOPHARM

Natco Pharma Ltd.

₹ 1207.10

+2.76%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1875.00

+1.47%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 17570.00

-0.54%

IPCALAB

Ipca Laboratories Ltd.

₹ 1538.00

-0.94%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2212.70

+2.93%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8624.00

+1.54%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2435.80

-1.66%

PFIZER

Pfizer Ltd.

₹ 4880.00

+1.27%

ABBOTINDIA

Abbott India Ltd.

₹ 27670.00

+3.63%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4516.60

+3.10%

LUPIN

Lupin Ltd.

₹ 2244.90

-5.66%

CIPLA

Cipla Ltd.

₹ 1305.50

-3.08%

FAQ's on DRREDDY

What is the current share price of Dr. Reddy's Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Dr. Reddy's Laboratories Ltd. is ₹ 1281.7 on the NSE and ₹ 1282.15 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Dr. Reddy's Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Dr. Reddy's Laboratories Ltd. is approximately ₹ 106827.7 Cr.

What are the PE and PB ratios for Dr. Reddy's Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Dr. Reddy's Laboratories Ltd. is 19.2, and the Price-to-Book (PB) ratio is 2.9.

What is the 52-Week High and Low for Dr. Reddy's Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Dr. Reddy's Laboratories Ltd. shares was ₹ 1379.7, and the lowest price was ₹ 1143.9.

What is the current dividend yield for Dr. Reddy's Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Dr. Reddy's Laboratories Ltd. is 0.6%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Dr. Reddy's Laboratories Ltd.?

Significant shareholdings in Dr. Reddy's Laboratories Ltd. typically include entities such as:

Other Institutions
Promoter
FII
Mutual Funds
Public

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Dr. Reddy's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Dr. Reddy's Laboratories Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. last declared a FINAL dividend of ₹ 8 per share for the financial period ending 2025. The record date was set as 2025-07-10, and the payment was/is scheduled around 2025-07-10. For the most current dividend announcements, refer to official company filings.